V
Vera Therapeutics, Inc. (VERA)
NGM – Real Time Price. Currency in USD
36.70
+0.09 (0.25%)
At close: May 12, 2026, 4:00 PM EDT
36.78
+0.08 (0.22%)
After-hours: May 12, 2026, 7:52 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
36.70
+0.09 (0.25%)
At close: May 12, 2026, 4:00 PM EDT
36.78
+0.08 (0.22%)
After-hours: May 12, 2026, 7:52 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 13.64 | 6.05 | 10 | |
| Quick ratio | 13.64 | 5.63 | 10 | |
| Debt to Equity | 0.15 | 0.30 | 9.0 | |
| Debt to Assets | 0.12 | 1.04 | 8.0 | |
| Interest coverage | -68.78 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | 846K | 2M | -2M | -468K | -2M |
| Operating Income | -91M | -102M | -167M | -315M | -383M |
| Net Income | -89M | -96M | -152M | -300M | -369M |
| EBITDA | -92M | -104M | -165M | -315M | -382M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -26.67 | 1.0 |
| Next quarter | N/A | -16.11 | 1.0 |
| Current year | N/A | -20.09 | 1.0 |
| Next year | 534.45 | 39.72 | 10 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -32.85 | -21.57 | -52.17 | 3.3 |
| Y/Y | 999 | -134.12 | -108.63 | -95.39 | 3.3 |
| 3y average | 999 | -54.38 | -19.59 | -53.85 | 3.3 |
| 5y average | 999 | -59.45 | 0.13 | -62.96 | 3.5 |
| Weighted average score | 3.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $114.4M significantly exceed its total debt $76.9M, ensuring strong financial flexibility
Total current assets $615.8M exceed Total current liabilities $45.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-68.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$106.7M limits the company's ability to reinvest or pay down debt